Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter [3]

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 301-302

  Cachat, Francois ^a   Bardy, Daniel ^a   Durussel, Claudine ^a   Di Paolo, Ermindo ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Alteplase; Chronic kidney disease; Hemodialysis; Hyperphosphatemia; Phosphate

Indexed keywords

ALTEPLASE; BUFFER; HEPARIN; PARAPROTEIN; PHOSPHATE; PHOSPHORIC ACID; PHOSPHORUS; UROKINASE;

BLOOD CLOT LYSIS; BLOOD SAMPLING; CASE REPORT; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CHEMICAL ANALYSIS; CHRONIC KIDNEY FAILURE; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERPHOSPHATASEMIA; HYPERPHOSPHATEMIA; KIDNEY BLOOD FLOW; LETTER; MALE; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; VASCULAR ACCESS;

CATHETERIZATION, CENTRAL VENOUS; CHILD, PRESCHOOL; FIBRINOLYTIC AGENTS; HUMANS; MALE; PHOSPHORUS METABOLISM DISORDERS; RENAL DIALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 30944449092     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2088-1     Document Type: Letter

References (10)

1. Dunea G, Domenico L, Gunnerson P, Winston-Willis F (1991) A survey of permanent double lumen catheters in hemodialysis patients. ASAIO Trans 37:M276-277 1751147
2. Daeihagh P, Jordan P, Chen J, Rocco M (2000) Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 36:75-79 10873875
3. Gittins M, Coulthard MG, Matthews JNS (2005) Alteplase v Heparin locks to maintain central line patency in hemodialysis lines. Arch Dis Child 90 [Suppl 11]:A30
4. Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O (2000) Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis 35:130-136 10620554
5. McBryde KD, Wilcox J, Kher KK (2005) Hyperphosphatemia due to fosphenytoin in a pediatric ESRD patient. Pediatr Nephrol 20:1182-1185 10.1007/s00467-005-1947-0
6. Rowe RC, Sheskey PJ, Weller PJ (2003) Handbook of pharmaceutical excipients, 4th edn. Pharmaceutical Press, London, pp 442-443
7. Ball CL, Tobler K, Ross BC, Connors MR, Lyon ME (2004) Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter. Clin Chem Lab Med 42:107-108 10.1515/ CCLM.2004.021
8. Cohen AM, Magazanik A, van-der Lijn E, Shaked P, Levinsky H (1994) Pseudohyperphosphatemia incidence in an automatic analyzer. Eur J Clin Chem Clin Biochem 32:559-561 7981338
9. Mandry JM, Posner MR, Tucci JR, Eil C (1991) Hyperphosphatemia in multiple myeloma due to a phosphate binding immunoglobulin. Cancer 68:1092-1094 1913479
10. Lelhey DJ, Daugirdas JT, Ing TS, Reid RW (1985) Spurious hyperphosphatemia due to hyperlipidemia. Arch Int Med 145:743-744 10.1001/archinte.145.4.743